Huya’s Foreign Clinical Advisory Team Includes Topol, Kowey

SHANGHAI - Huya Bioscience has established a foreign clinical advisory team to collaborate with Huya's Chinese partners on clinical trials in China and the U.S. for the anti-arrhythmic compound HBI-3000 (sulcardine sulphate), the San Diego company announced March 3